Aprea Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Aprea Therapeutics, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 3/3Sales grew in 0 of the last 3 years; profit grew in 3 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Aprea Therapeutics, Inc. made a loss over the last year. Aprea Therapeutics, Inc. owes $0.09 for every $1 it owns. Aprea Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAprea Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.18The share price is 0.18 times Aprea Therapeutics, Inc.'s book value per share, lower than 98% of Healthcare companies in United States.
Market cap
$7 MThe total market value of all of Aprea Therapeutics, Inc.'s shares at today's price (share price × number of shares), smaller than 91% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$38 MWhat Aprea Therapeutics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.06Net worth divided by the number of shares. The share price of $0.54 is 0.2 times this, which is the P/B above.
Return on equity (ROE)
-46.1%Aprea Therapeutics, Inc. lost 46.1% of its shareholders' money over the last year, higher than 51% of Healthcare companies in United States.
Owes vs Owns
0.09×Aprea Therapeutics, Inc. owes $0.09 for every $1 it owns (low), lower than 88% of Healthcare companies in United States.
Dividend yield
NoneAprea Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossAprea Therapeutics, Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Aprea Therapeutics, Inc.: $7 M ÷ $38 M (30 Jun 2026) = 0.2.
What is Aprea Therapeutics, Inc.'s return on equity?
Aprea Therapeutics, Inc. lost 46.1% of its shareholders' money over the last year, higher than 51% of Healthcare companies in United States.
How much does Aprea Therapeutics, Inc. owe compared with what it owns?
Aprea Therapeutics, Inc. owes $0.09 for every $1 it owns (low), lower than 88% of Healthcare companies in United States.
Does Aprea Therapeutics, Inc. pay a dividend?
No. Aprea Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.